Talis Biomedical Corporation (TLIS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Talis Biomedical Corporat...

    OTC: TLIS · Real-Time Price · USD
    1.06
    -0.54 (-33.75%)
    At close: Apr 04, 2025, 9:37 AM

    Talis Biomedical Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -62.01M -113.01M -192.04M
    Depreciation & Amortization
    		 770K 8.83M 1.58M
    Stock-Based Compensation
    		 4.35M 5.37M 9.21M
    Other Working Capital
    		 -1.25M -6.37M 8.61M
    Other Non-Cash Items
    		 7.07M 6.36M 1.04M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 -3.42M -7.69M 8.82M
    Operating Cash Flow
    		 -53.24M -100.14M -171.38M
    Capital Expenditures
    		 -486K -1.61M -2.87M
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -486K -1.61M -2.87M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 33K 406K 1.88M
    Financial Cash Flow
    		 33K 406K 234.43M
    Net Cash Flow
    		 -53.69M -101.34M 60.18M
    Free Cash Flow
    		 -53.73M -101.75M -174.25M

    Add to Watchlist